Rob Stein i
Maggie Starbard/NPR
Rob Stein
Maggie Starbard/NPR

Rob Stein

Correspondent and Senior Editor, Science Desk

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

[+] full biography[-] full biography

Microwave popcorn containing trans fats from November 2013. The Grocery Manufacturers Association says the industry has lowered the amount of trans fat added to food products by more than 86 percent. But trans fats can still be found in some processed food items. Shannon Stapleton/Reuters/Landov hide caption

itoggle caption Shannon Stapleton/Reuters/Landov

Kevin Lopez makes breakfast with his sister Jenny. He is waiting for a donor hand to remedy a genetic defect. Meredith Rizzo/NPR hide caption

itoggle caption Meredith Rizzo/NPR

The experimental drug flibanserin, made by Sprout Pharmaceuticals, is at the center of a regulatory controversy. Allen Breed/AP hide caption

itoggle caption Allen Breed/AP

Psyched that it's finally spring? Shifts in the season may affect more than your mood. Corbis hide caption

itoggle caption Corbis

Cambrian Genomics says that what it calls a DNA printer is essentially a DNA sorter — it quickly spots and collects the desired, tailored stretch of DNA. Courtesy of Cambrian Genomics hide caption

itoggle caption Courtesy of Cambrian Genomics
iStockphoto

Mmm. Smells just like your identical twin. iStockphoto hide caption

itoggle caption iStockphoto
iStockphoto

NPR intern Poncie Rutsch takes a crack at making a big sound. Meredith Rizzo/NPR hide caption

itoggle caption Meredith Rizzo/NPR

Kevin Lopez at home in Greenbelt, Md. Meredith Rizzo/NPR hide caption

itoggle caption Meredith Rizzo/NPR